Ulinastatin Attenuates Lung Ischemia-Reperfusion Injury in Rats by Inhibiting Tumor Necrosis Factor Alpha

References 

1. Barr ML, Schenkel FA, Bowdish ME, et al. Living donor lobar lung transplantation: current status and future directions. Transplant Proc. 2005;379:3983
2. Lau CL, Patterson GA. Current status of lung transplantation. Eur Respir J. 2003;47suppl:575
3. Nishiyama T, Hanaoka K. Do the effects of a protease inhibitor, ulinastatin, on elastase release by blood transfusion depend on interleukin 6?. Crit Care Med. 2001;29:2106
   • MEDLINE
   • CrossRef
4. Watanabe T, Sato Y, Ichida T, et al. Comparison of urinary ulinastatin levels between donors and recipients immediately following adult living related donor liver transplantation. Transplant Proc. 2003;35:76
   • Full Text
   • Full-Text PDF (69 KB)
   • CrossRef
5. Khan SU, Salloum J, O’Donovan PB, et al. Acute pulmonary edema after lung transplantation: the pulmonary reimplantation response. Chest. 1999;116:187
   • MEDLINE
   • CrossRef
6. Allison RC, Kyle J, Adkins WK, et al. Effect of ischemia reperfusion or hypoxia reoxygenation on lung vascular permeability and resistance. J Appl Physiol. 1990;69:597
   • MEDLINE
7. Aiba M, Takeyoshi I, Sunose Y, et al. FR167653 ameliorates pulmonary damage in ischemia-reperfusion injury in a canine lung transplantation model. J Heart Lung Transplant. 2000;19:879
   • Abstract
   • Full Text
   • Full-Text PDF (380 KB)
   • CrossRef
8. Seekamp A, Ward PA. Ischemia-reperfusion injury. Agents Actions. 1993;41(suppl):137